HealthFinSMEsabout 2 hours ago
Quantro Receives Austrian Research Grant
1 min read
Quantro Therapeutics receives a 12-month non-dilutive research grant from the Austrian Research Promotion Agency on 04/11/2026. The deal amount remains undisclosed. CEO Michael Bauer leads the Vienna-based firm developing the ASCEND AI-driven medicinal chemistry platform to optimize small molecule modulators and degraders for cancer and inflammation disorders.
Level
Hype check
Tap to vote and see what everyone thinks.
